Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VA study aims to get more veterans lifesaving opioid treatment

NCT ID NCT04178551

Knowledge-focused Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how to help more veterans with opioid use disorder get effective medication. Researchers combined six pilot projects across 63 VA sites to find the best ways to increase access to these treatments. The goal was to see if a structured support program for healthcare teams could boost the number of patients starting and staying on medication for opioid use disorder.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Implementation facilitation (a structured support program for healthcare teams)
What this could lead to
If successful, this could show how to increase access to opioid use disorder medications across the VA, helping more veterans get treatment.
What could go wrong
This is an implementation study, not a test of a new drug or therapy. It focuses on improving how existing treatments are delivered, so it won't directly create a new cure or medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

63 people

The number who actually took part.

Started

Oct 2019

Finished

Sep 2022

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: -All Veterans on prescribed opioid treatment and/or with opioid use disorder who are enrolled at participating implementation sites. Exclusion Criteria: -None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioid medication assisted treatment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Opioid medication assisted treatment

Contacts and locations

Locations

  • Birmingham VA Medical Center, Birmingham, AL

    Birmingham, Alabama, 35233, United States

  • Boise VA Medical Center, Boise, ID

    Boise, Idaho, 83702, United States

  • Iowa City VA Health Care System, Iowa City, IA

    Iowa City, Iowa, 52246-2208, United States

  • Maine VA Medical Center, Augusta, ME

    Augusta, Maine, 04330, United States

  • Rocky Mountain Regional VA Medical Center, Aurora, CO

    Aurora, Colorado, 80045, United States

  • VA Central Western Massachusetts Healthcare System, Leeds, MA

    Leeds, Massachusetts, 01053-9764, United States

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT

    West Haven, Connecticut, 06516-2770, United States

  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA

    West Los Angeles, California, 90073, United States

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA

    Seattle, Washington, 98108, United States

  • VA Salt Lake City Health Care System, Salt Lake City, UT

    Salt Lake City, Utah, 84148, United States

  • Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC

    Columbia, South Carolina, 29209, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.